Lyme Vaccine Shows Promise, but 'Tricky' Path Lies Ahead

A potential comeback for a Lyme disease vaccine just cleared a big, but not decisive, hurdle. Pfizer and French drugmaker Valneva say their experimental shot cut Lyme infections by more than 70% in a late-stage trial of 9,400 people ages 5 and up—strong enough that they plan to...